Lilly Buys Rights To Intranasal Diabetes Treatment

Eli Lilly & Co. said Friday it bought the rights to a potential treatment for severe hypoglycemia in people with diabetes from Locemia Solutions.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.